Olema Pharmaceuticals CEO Sean Bohen receives $11M in 2020
Olema Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 27, 2021
Olema Pharmaceuticals reported fiscal year 2020 executive compensation information on April 27, 2021.
In 2020, four executives at Olema Pharmaceuticals received on average a compensation package of $5.2M, a 1,962% increase compared to previous year.
Average pay of disclosed executives at Olema Pharmaceuticals
Sean Bohen, Chief Executive Officer, received $11M in total. 97% of Bohen's compensation, or $10M, was in option awards. Bohen also received $109K in non-equity incentive plan and $178K in salary.
Cyrus Harmon, Chief Executive Officer, received a compensation package of $4M, which increased by 1226% compared to previous year. 75% of the compensation package, or $3M, was in option awards.
Peter J. Kushner, Chief Scientific Officer, earned $3M in 2020, a 1412% increase compared to previous year.
John B. Moriarty, Chief Legal Officer, received $3M in 2020.
Related executives
You may also like
Source: SEC filing on April 27, 2021.